In June 2005, the Medicines and Healthcare Products Regulatory Agency (MHRA) announced it was reclassifying chloramphenicol eye drops for the treatment of acute bacterial conjunctivitis so that ...

We observed crystalline precipitate on combination of timolol maleate and chloramphenicol eye drops. The precipitate ... and preservative-free 0.1% dexamethasone minims were added 4 weeks later.

Santen EMEA and NTC are delighted to announce that the results of their phase III clinical study, LEADER7, have been published in Eye. The study demonstrated for the first time that 7-day ...

The Food and Drug Administration (FDA) has approved Dextenza (dexamethasone ophthalmic insert ... “Compliance with taking eye drops after eye surgery is very challenging for patients and ...

The latest findings question how appropriately chloramphenicol drops and ointment are being used for eye complaints, and experts have again warned of the risks of fuelling demand for antibiotics. The ...

The decision to reclassify chloramphenicol was made after holding a consultation period during which health professionals and the public could offer their views on the proposed change. The drug, sold ...

DEXYCU employs the Company's Verisome sustained-release drug delivery technology to deliver a biodegradable extended-release formulation of the steroid dexamethasone into the posterior chamber of ...

ALTHOUGH well known as a cause of aplastic anemia, 1–4 chloramphenicol (Chloromycetin) is used widely because of the rarity of this reaction and the clinical advantages of the antibiotic.